EP1214101A4 - Verfahren zur lokalisierung und zum abtöten von epithelialen krebszellen - Google Patents

Verfahren zur lokalisierung und zum abtöten von epithelialen krebszellen

Info

Publication number
EP1214101A4
EP1214101A4 EP01916271A EP01916271A EP1214101A4 EP 1214101 A4 EP1214101 A4 EP 1214101A4 EP 01916271 A EP01916271 A EP 01916271A EP 01916271 A EP01916271 A EP 01916271A EP 1214101 A4 EP1214101 A4 EP 1214101A4
Authority
EP
European Patent Office
Prior art keywords
localizing
brazing
cancer cells
epithelial cancer
epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01916271A
Other languages
English (en)
French (fr)
Other versions
EP1214101A1 (de
Inventor
Samuel D Bernal
Douglas D Burkett
Ralph E Green
Seth D Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zila Inc
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Publication of EP1214101A1 publication Critical patent/EP1214101A1/de
Publication of EP1214101A4 publication Critical patent/EP1214101A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP01916271A 2000-02-28 2001-02-27 Verfahren zur lokalisierung und zum abtöten von epithelialen krebszellen Ceased EP1214101A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2000/005387 WO2001064110A1 (en) 2000-02-28 2000-02-28 Method for detecting and killing epithelial cancer cells
WOPCT/US00/05387 2000-02-28
PCT/US2001/006318 WO2001064255A1 (en) 2000-02-28 2001-02-27 Method for detecting and killing epithelial cancer cells

Publications (2)

Publication Number Publication Date
EP1214101A1 EP1214101A1 (de) 2002-06-19
EP1214101A4 true EP1214101A4 (de) 2005-04-13

Family

ID=21741108

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01916271A Ceased EP1214101A4 (de) 2000-02-28 2001-02-27 Verfahren zur lokalisierung und zum abtöten von epithelialen krebszellen

Country Status (14)

Country Link
EP (1) EP1214101A4 (de)
JP (1) JP2003525044A (de)
KR (2) KR20080080681A (de)
CN (1) CN100544770C (de)
AU (2) AU2000237154A1 (de)
BR (1) BR0104747A (de)
CA (1) CA2370741A1 (de)
CZ (1) CZ20013861A3 (de)
IL (1) IL146141A0 (de)
MX (1) MXPA01010886A (de)
NO (1) NO20015242L (de)
NZ (1) NZ515202A (de)
RU (1) RU2226404C2 (de)
WO (2) WO2001064110A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064110A1 (en) * 2000-02-28 2001-09-07 Zila, Inc. Method for detecting and killing epithelial cancer cells
AU784558B2 (en) * 2000-06-30 2006-05-04 Zila Biotechnology, Inc. Rhodamine diagnostic agent and diagnostic methods for detections of epithelial cancer
JP2004509637A (ja) * 2000-09-26 2004-04-02 ジラ・インコーポレーテッド 浸潤癌の発生の早期予測のための方法
MXPA04002659A (es) * 2001-12-14 2004-06-18 Zila Inc Analisis molecular dirigido por tincion para pronostico y diagnostico de cancer.
US6890571B2 (en) 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
US6929817B2 (en) 2002-05-14 2005-08-16 National Starch & Chemical Investment Holding Corporation Slowly digestible starch product
MXPA04012031A (es) * 2002-06-04 2005-03-07 Zila Biotechnology Inc Sustancia farmacologica azul de toluidina o y su uso para tincion in vivo y quimioterapia de tejidos displasicos.
CA2583427A1 (en) * 2004-09-30 2006-04-20 Zila Biotechnology, Inc. Light-directed method for detecting and aiding further evaluation of abnormal mucosal tissue
US20090196850A1 (en) 2005-01-06 2009-08-06 Novo Nordisk A/S Anti-Kir Combination Treatments and Methods
RU2367365C1 (ru) * 2008-03-19 2009-09-20 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Способ хирургического лечения плоскоклеточного рака кожи без метастазов в регионарные лимфатические узлы
CN102497868A (zh) 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
CN105510321A (zh) * 2011-12-29 2016-04-20 闫文广 用于上皮组织肿瘤细胞的检测剂组合物及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
US5882627A (en) * 1996-01-16 1999-03-16 Zila Pharmaceuticals, Inc. Methods and compositions for in-vivo detection of oral cancers precancerous conditions
WO2000037107A2 (en) * 1998-12-23 2000-06-29 G.D. Searle & Co. Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
WO2001064110A1 (en) * 2000-02-28 2001-09-07 Zila, Inc. Method for detecting and killing epithelial cancer cells
WO2002007693A1 (en) * 2000-07-20 2002-01-31 Zila, Inc. Improved diagnostic method for detecting dysplastic epithelial tissue
WO2002026266A1 (en) * 2000-09-26 2002-04-04 Zila, Inc. Method for early prediction of the onset of invasive cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194373A (en) * 1985-06-06 1993-03-16 Thomas Jefferson University Method of determining endothelial cell coverage of a prosthetic surface
US4816395A (en) * 1985-12-19 1989-03-28 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
DK0565668T3 (da) * 1991-10-31 2000-01-31 Zila Inc Biologisk farvemiddelsammensætning, fremgangsmåde til fremstilling deraf og til anvendelse til aftegning af epitelcancer
RU2127429C1 (ru) * 1995-06-06 1999-03-10 Эммануил Маркович Коган Способ диагностики гиперпластических процессов и рака эндометрия
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
US5882627A (en) * 1996-01-16 1999-03-16 Zila Pharmaceuticals, Inc. Methods and compositions for in-vivo detection of oral cancers precancerous conditions
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
WO2000037107A2 (en) * 1998-12-23 2000-06-29 G.D. Searle & Co. Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
WO2001064110A1 (en) * 2000-02-28 2001-09-07 Zila, Inc. Method for detecting and killing epithelial cancer cells
WO2002007693A1 (en) * 2000-07-20 2002-01-31 Zila, Inc. Improved diagnostic method for detecting dysplastic epithelial tissue
WO2002026266A1 (en) * 2000-09-26 2002-04-04 Zila, Inc. Method for early prediction of the onset of invasive cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEN L B ET AL: "STUDIES OF MITOCHONDRIA IN CARCINOMA CELLS WITH RHODAMINE 123", WEINSTEIN, I. B. AND H. J. VOGEL (ED.). P AND S BIOMEDICAL SCIENCES SYMPOSIA: GENES AND PROTEINS IN ONCOGENESIS; JUNE 4-6, 1982. XXI+403P. ACADEMIC PRESS, INC.: NEW YORK, N.Y., USA; LONDON, ENGLAND. ILLUS, 1983, pages P369 - 387, XP008043059, ISSN: 0-12-742420-2 *
GABRIELLI D. ET AL: "Binding, Aggregation and Photochemical Properties of Methylene Blue in Mitochondrial Suspensions", PHOTCHEMISTRY AND PHOTOBIOLOGY, vol. 79, no. 3, 2004, pages 227 - 232 *
LILEY D.T.J. ET AL: "Localization of Nonintercalative DNA Binding Antitumour Drug in Mitochondria: Relationship to Multidrug Resistance", EUROPEAN JOURNAL OF CLINICAL ONCOLOGY, vol. 25, no. 9, 1989, pages 1287 - 1293, ISSN: 0277-5379 *
See also references of WO0164255A1 *
SUN X. ET AL: "Anticarcinoma Activity of a Novel Drug, 3-Ethyl-3'-methyl-thiatelluracarbocyanine Idiode (Te), a Tellurium-containing Cyanine Targeted at Mitochondria", CLINICAL CANCER RESEARCH, vol. 2, August 1996 (1996-08-01), United States, pages 1335 - 1340, ISSN: 1078-0432 *

Also Published As

Publication number Publication date
NZ515202A (en) 2003-05-30
KR100907122B1 (ko) 2009-07-09
RU2226404C2 (ru) 2004-04-10
CA2370741A1 (en) 2001-09-07
JP2003525044A (ja) 2003-08-26
KR20080080681A (ko) 2008-09-04
WO2001064110A1 (en) 2001-09-07
WO2001064255A1 (en) 2001-09-07
CN1365288A (zh) 2002-08-21
AU785489B2 (en) 2007-11-15
CZ20013861A3 (cs) 2002-08-14
CN100544770C (zh) 2009-09-30
AU4331601A (en) 2001-09-12
NO20015242L (no) 2001-11-29
EP1214101A1 (de) 2002-06-19
AU2000237154A1 (en) 2001-09-12
IL146141A0 (en) 2002-07-25
BR0104747A (pt) 2002-09-17
NO20015242D0 (no) 2001-10-26
KR20020000222A (ko) 2002-01-05
MXPA01010886A (es) 2002-05-06

Similar Documents

Publication Publication Date Title
DE60120822D1 (de) Meta-Dokument und Verfahren zum Verwalten von Meta-Dokumenten
ATE412107T1 (de) Verfahren und system zum perforieren
DE60138132D1 (de) Verfahren zur gleichzeitigen coproduktion und reinopylester
DE60022304D1 (de) Verfahren und Anordnung zur Ortung von Sprechern
DE60228160D1 (de) System und Verfahren zum Durchführen von drahtlosen Transaktionen
DE60134383D1 (de) Vorrichtung und Verfahren zum Sammeln von Datenverkehrsinformationen
DE10196232T1 (de) HF-Leistungsverstärker und Verfahren zur Verbesserung dessen Wirkungsgrades
DE60133166D1 (de) Verfahren und Vorrichtung zur Volumendarstellung
DE60107142D1 (de) Verfahren und Vorrichtung zur Detektierung von Schalterbetätigungen
DE60017188D1 (de) Verfahren zur umsetzung von synthesegas in höheren kohlenwasserstoffen
AU3290201A (en) Anastomosis instrument and method for performing same
DE50012519D1 (de) Verfahren zur fahrwegvisualisierung und vorrichtung
DE60138344D1 (de) Verfahren zur Mutagenese
DE60309299D1 (de) System und Verfahren zur Ablaufverfolgung von Banknoten
DE60108832D1 (de) Verfahren zum Ablesen von Fluoreszenz
DE10197118T1 (de) Verfahren und Vorrichtung zum Herstellen von Kleidungsstücken
DE60133316D1 (de) System und verfahren zum abfangen von telekommunikationen
DE60132243D1 (de) Verfahren zum indizieren von entitäten
DE60136763D1 (de) Metallisierungsgerät und Verfahren zur Entfernung von Metallisierungsflüssigkeit
EP1214101A4 (de) Verfahren zur lokalisierung und zum abtöten von epithelialen krebszellen
DE60124884D1 (de) Verfahren zur verbesserung der fotomaskengeometrie
DE60119403D1 (de) Vorrichtung und Verfahren zum Ändern von Karteninformationen
ATE472733T1 (de) Verfahren zur beurteilung von zellulären proliferativen erkrankungen
DE50109140D1 (de) Verfahren und Vorrichtung zum Temperieren von Proben
ATE285678T1 (de) Verfahren und vorrichtung zum einfrieren von gewebe

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020225

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: RO

A4 Supplementary search report drawn up and despatched

Effective date: 20050228

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 49/00 A

Ipc: 7A 61B 10/00 B

Ipc: 7A 61K 31/54 B

Ipc: 7A 61P 35/00 B

17Q First examination report despatched

Effective date: 20060601

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20091013